Document is current
Any future updates will be listed below
-
Authors
Mukherjee, Siddhartha
Garda, Cindy https://orcid.org/0009-0003-7582-2527
Boffa, Letizia https://orcid.org/0009-0001-2789-0264
Elia, Angela Rita
Massara, Matteo https://orcid.org/0000-0001-6724-5633
Balia, Maria Teresa
Brina, Daniela
Mosole, Simone
Campagnari, Anna
Cassanmagnago, Giada Andrea https://orcid.org/0000-0001-8803-5344
Rinaldi, Andrea
Lazzaroni, Giacomo
Jarrossay, David
Morone, Diego https://orcid.org/0000-0002-6847-3811
Ceppi, Ilaria https://orcid.org/0000-0001-6496-8983
De Sillo, Riccardo
Giacomini, Isabella
Craparotta, Ilaria
Di Rito, Laura
Barry, Simon https://orcid.org/0000-0002-8511-0588
Laczko, Endre
Streb, Sebastian https://orcid.org/0000-0002-9095-6596
Meani, Francesco
Di Lascio, Simona
Hynes, Nancy https://orcid.org/0000-0001-8802-2316
Lugli, Enrico https://orcid.org/0000-0002-1964-7678
Puccio, Simone https://orcid.org/0000-0003-4007-4365
Sammut, Stephen-John
Perriard, Ulrike
Harder, Yves
Rossi, Lorenzo
Gasparri, Maria Luisa
Bolis, Marco https://orcid.org/0000-0003-4377-5079
Cejka, Petr https://orcid.org/0000-0002-9087-032X
Calcinotto, Arianna https://orcid.org/0000-0003-1746-6424
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF 310030_219673, TMSGI3_218488)
Fondazione IOR, a Peter Hans Hofschneider Professorship grant, the Pierre Mercier Foundation, San Salvatore Foundation, Ticino Cancer League
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 23 June 2025
First Online: 30 July 2025
Competing interests
: The authors declare that Dr. Simon Barry is affiliated with IMED Oncology AstraZeneca, Li Ka Shing Center, Cambridge, United Kingdom and provided the αCXCR2 compound. The authors declare no competing interests.
